![Rightmove Rewarded by Tough Housing Market: The London Rush](/i/c/1a293376-086b-a0c8-779c-2e8168643ab0.webp)
Rightmove Rewarded by Tough Housing Market: The London Rush
Hi, I’m Leo from Bloomberg’s UK Breaking News team, catching you up on this morning’s business stories. There’s
2023-11-27 16:45
![GSK Says Blood Cancer Drug Helped Patients in Study](/i/c/fc75c918-fa87-d100-c5c4-5a6aaa5541fb.webp)
GSK Says Blood Cancer Drug Helped Patients in Study
GSK Plc said its antibody drug Blenrep, which had its US clearance revoked last year, helped patients live
2023-11-27 16:19
![GSK Lifts Outlook Again After Strong Sales of New RSV Shot](/i/c/b8d95671-a87d-dbc8-b39a-374af78bfdaa.webp)
GSK Lifts Outlook Again After Strong Sales of New RSV Shot
GSK Plc raised its guidance for the second time this year as demand surges for its breakthrough vaccine
2023-11-01 16:18
![GSK Says Jemperli Helped Extend Lives of Cancer Patients](/i/c/aafe1139-08d2-c09b-b4d9-e0d7d3f0751b.webp)
GSK Says Jemperli Helped Extend Lives of Cancer Patients
GSK Plc’s Jemperli helped extend the lives of patients with endometrial cancer in a late-stage test, suggesting the
2023-10-30 16:20
![Drugmaker GSK settles another California lawsuit on heartburn drug Zantac](/i/c/94353ffd-2723-3c01-9405-bb4eeabdccaa.webp)
Drugmaker GSK settles another California lawsuit on heartburn drug Zantac
(Reuters) -GSK on Wednesday said it would confidentially settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused
2023-10-11 15:58
![GSK Settles Zantac Lawsuit Set for Trial in California](/i/c/fe9f7904-ad06-81c5-12c9-005a23892a72.webp)
GSK Settles Zantac Lawsuit Set for Trial in California
GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.
2023-10-11 15:46
![Companies Get Renewed Pressure to Disclose Nature-Related Risks](/i/c/7cc22620-ebee-d539-2c30-1a959e6f0a1a.webp)
Companies Get Renewed Pressure to Disclose Nature-Related Risks
Executives from companies, banks and asset managers published guidelines aimed at helping businesses disclose the risks they face
2023-09-19 06:47
![GSK’s Nigerian Unit to Close Down, Return Cash](/i/c/d16ac748-3cbe-bb4d-3d8a-fd9df1c102dc.webp)
GSK’s Nigerian Unit to Close Down, Return Cash
GlaxoSmithKline Consumer Nigeria Plc, the second-biggest drug firm in the West African nation, will cease operations after its
2023-08-04 16:47
![GSK Raises Outlook, Looks to New Medicines to Fuel Growth](/i/c/df7351e0-8306-49f2-9ded-9d47c34aabca.webp)
GSK Raises Outlook, Looks to New Medicines to Fuel Growth
GSK Plc raised its guidance for the year after a strong start to 2023 as it prepares to
2023-07-26 15:18
![Paragon Flags Disruption in Buy-to-Let Market: The London Rush](/i/c/46e26b90-c7e7-8fb0-ba06-1a189124d61b.webp)
Paragon Flags Disruption in Buy-to-Let Market: The London Rush
A recent surge in mortgage rates has led to fewer applications for buy-to-let products, Paragon said in a
2023-07-25 15:15
![GSK soothes investors by settling first Zantac cancer lawsuit due for US trial](/i/c/73e12071-4c83-8421-3f85-9edbee61aa56.webp)
GSK soothes investors by settling first Zantac cancer lawsuit due for US trial
By Natalie Grover and Eva Mathews (Reuters) -GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac
2023-06-23 19:26
![GSK Settles First Zantac Case Set for US Trial: The London Rush](/i/c/b9673645-7afd-63f8-1b4f-0dceb1ff3fdd.webp)
GSK Settles First Zantac Case Set for US Trial: The London Rush
GSK’s first settlement of a lawsuit in the Zantac litigation may set the momentum ahead of a sequence
2023-06-23 15:26